CorMedix(CRMD) - 2025 Q4 - Earnings Call Transcript

CorMedix (NasdaqGM:CRMD) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsBrandon Folkes - Managing DirectorDan Ferry - Managing DirectorJeevan Larson - Equity Research AssociateJoe Todisco - Chairman and CEOJohn Todaro - Managing DirectorLiz Hurlburt - EVP and COOSusan Blum - EVP and CFOConference Call ParticipantsRoanna Ruiz - Senior Managing Director and Senior Biotechnology AnalystOperatorGood morning, and welcome to the CorMedix fourth quarter and full year 2025 earnings and corpora ...